Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

HPRG-induced downregulation of PlGF shows anticancer potential

Jan. 13, 2011

UCB claims new PI3K inhibitors

Jan. 13, 2011

Seattle Genetics and Pfizer join to develop anticancer antibody-drug conjugates

Jan. 12, 2011

Cylene Pharmaceuticals identifies novel protein kinase inhibitors

Jan. 12, 2011

Antimalarial artesunate has anticancer properties that can be enhanced by combination therapy

Jan. 12, 2011

Enrollment begins in phase III regorafenib trial in gastrointestinal stromal tumors

Jan. 11, 2011

Eusa Pharma obtains FDA priority review status for Erwinaze BLA

Jan. 11, 2011

Abraxis claims new proto-oncogene tyrosine-protein kinase Src inhibitors

Jan. 11, 2011

TopoTarget patents new NAmPRTase inhibitors

Jan. 11, 2011

Inhibition of HSP 90 is efficacious in MET-amplified tumor cells

Jan. 10, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...